Invasc Adds Two Leaders to Scientific Advisory Board
Date: Apr 06 2012
ATLANTA, Georgia – April 5, 2012 – InVasc Therapeutics, Inc., a leading developer of drugs for chronic kidney and cardiometabolic diseases, announced today that two thought leaders, George L. Bakris, M.D. and Gordon H. Williams, M.D., have been appointed to InVasc’s Scientific Advisory Board (SAB). These distinguished clinician-scientists will provide guidance to InVasc as it advances its portfolio of products through preclinical and clinical development. 